Approach

Down's syndrome (DS) can be definitively diagnosed prenatally via chorionic villus sampling or amniocentesis, or after birth based on the physical findings on the newborn examination leading to karyotype analysis. Chromosomal studies are necessary to both confirm the clinical suspicion and to determine whether the child has standard trisomy 21, a chromosome translocation, or mosaicism.

Physical characteristics

Physical exam within the first 24 hours of life is the most sensitive test for identifying possible DS. Suspicion for DS should prompt confirmation via a chromosomal karyotype test.[17]

The following 10 features of DS are typically present in the neonatal period:[18]

  • Hypotonia (80% of patients)

  • Poor Moro reflex (85% of patients)

  • Hyper-flexibility of joints (80% of patients)

  • Extra skin on back of neck (80% of patients)

  • Flat facial profile (90% of patients)

  • Slanted palpebral fissures (80% of patients)

  • Anomalous auricles (60% of patients)

  • Hypoplasia of iliac wings (70% of patients)

  • Short middle phalanx of the fifth finger (60% of patients)

  • Transverse palmar crease (45% of patients)

General examination in an infant or older child may reveal other findings, although not all features need to be present to suspect the diagnosis.[5][18][Figure caption and citation for the preceding image starts]: Girl with Down's syndromeFrom the personal collection of Dr Jeannie Visootsak; photo used with parental consent [Citation ends].com.bmj.content.model.Caption@24365b2e[Figure caption and citation for the preceding image starts]: Boy with mosaic Down's syndrome, diagnosed at 18 monthsFrom the personal collection of Dr Jeannie Visootsak; photo used with parental consent [Citation ends].com.bmj.content.model.Caption@7ee6255b[Figure caption and citation for the preceding image starts]: A 5-year-old boy with Down's syndromeFrom the personal collection of Dr Jeannie Visootsak; photo used with parental consent [Citation ends].com.bmj.content.model.Caption@1ba6a996

  • Skull: brachycephaly with a flat occiput

  • Eyes: epicanthal folds in addition to upslanting palpebral fissures, Brushfield spots of the iris

  • Nose: short, a low nasal bridge, small nares

  • Ears: small, may be low-set

  • Tongue: protruding

  • Mouth: down-turned, small oral cavity

  • Extremities: short hands, in addition to possible single palmar transverse creases, digital dermatoglyphics, and fifth finger clinodactyly. Wide space between first and second toes, with vertical plantar creases

Diagnosis made postnatally

Specific recommendations have been suggested for delivering the postnatal diagnosis of DS to the family:[17][19][20]

  • The person delivering the diagnosis should be a clinician with knowledge of DS, preferably an obstetrician and/or a paediatrician (or paediatric sub-specialist). Parents often prefer to receive the diagnosis together in a joint meeting with their obstetrician and paediatrician.

  • Because DS can be identified soon after birth, clinicians should inform parents of their suspicion immediately, even if the diagnosis has not been confirmed by karyotype.

  • Clinicians should deliver the diagnosis with both parents present in a private hospital room. The infant with DS should be present during the conversation and referred to by name, if one has been chosen.

  • The clinician should first congratulate the parents on the birth of their child and include information on the positive aspects of DS. Information on DS should be up to date and balanced.

  • Physicians should also provide parents with up-to-date printed material and resources, and can refer parents to support groups. ​Global Down Syndrome Foundation Opens in new window Down Syndrome Diagnosis Network Opens in new window

Diagnosis made antenatally

Specific recommendations have been suggested for delivering an antenatal diagnosis of DS to expectant parents:[21][22]

  • Contact with a local and/or online DS support group should be offered, if desired.

Childhood developmental delay

Many children with DS have global developmental delay. They often have hypotonia, ligamentous laxity, decreased strength, and short arms and legs relative to their trunk length. Motor milestones include rolling between 5.0 and 6.4 months, sitting independently by 14.4 months, crawling between 12.2 and 17.3 months, and walking independently by 54 months.[23][24][25]​​​ These milestones may also be impacted by medical conditions such as congenital heart disease (CHD) or hearing loss. 

There is typically a language delay that can be further affected by low muscle tone, small mouth with protruding tongue, and open-mouth posture. Difficulties in motor planning and in coordinating rapid movements of the tongue, lips, jaw, and palate affect speech intelligibility. Expressive language is more delayed than receptive language. Other language deficits include development of variability in the number of different words, intelligibility, and mean length of utterance. Overall, expressive language is more delayed than receptive language.​[25]​​[26]

Cognitive abilities of a person with DS vary greatly, with challenges in the expressive language domain and strengths in visual-spatial tasks. IQ can range from mild to moderate intellectual disability, between 40 and 72, and may decline with increasing age. The decline in IQ may be explained by a slowing of the developmental course over the childhood years.[27]

Individuals with DS are often social and affectionate, though they may experience challenges that differ from those of their typically developing peers. Some studies quote that 20% to 40% of people with DS have maladaptive behavioural problems. An age-related pattern of behavioural problems may be present: externalising behavioural problems (opposition, hyperactivity, impulsivity, inattention) are more common during childhood, and internalising symptoms (shyness, withdrawal, anxiety) are seen in older adolescents.[27]

Chromosomal analysis

Chromosomal studies are indicated to confirm the clinical suspicion and determine whether the karyotype is a standard trisomy 21, a chromosome translocation, or mosaicism. Translocation results require testing the parents to determine future recurrence risks.

Humans typically have 23 pairs of chromosomes (46 total chromosomes). The first 22 pairs are called autosomes and are similar in males and females. The 23rd pair of chromosomes are called sex chromosomes because they determine sex. The nomenclature of human chromosomes for a male is 46,XY and for a female is 46,XX.[12] Chromosomal variations in DS include:

  • Standard trisomy 21

    • An extra chromosome 21 from meiotic non-disjunction or failure of the chromosome pairs to separate during gamete formation is present in about 95% of individuals with DS.[12] Population-based studies show that over 90% of non-disjunction errors leading to trisomy 21 occur in the oocyte and predominantly in maternal meiosis I.[10][11]

    • The chromosomal karyotype for standard trisomy 21 is indicated as 47,XY,+21 in males and 47,XX,+21 in females.

  • Robertsonian translocation

    • About 4% of individuals with DS have 46 chromosomes, one of which is a Robertsonian translocation between 21q and the long arm of one of the other acrocentric chromosomes (typically chromosome 14 or 21).[12] The translocation chromosome replaces one of the acrocentric chromosomes. The karyotype of a person with DS and a Robertsonian translocation between chromosomes 14 and 21 is indicated as 46,XX or XY, der(14;21)(q10;q10),+21.

    • Translocation DS has a relatively high chance of recurrence in families when one of the parents is a carrier of the translocation. For these reasons, chromosomal karyotyping of the parents is essential to address the potential of recurrence in future pregnancies.

    • A 21q21q Robertsonian translocation is a chromosome consisting of two chromosome 21 long arms. It is rare. In this case, all gametes of a carrier chromosome contain the 21q21q chromosome, with a double dose of chromosome 21q and a lack of any chromosome 21p genetic material. A carrier of 21q21q translocation has a 100% rate of recurrence in having a child with 21q21q translocation.[12]

  • Mosaic

    • About 1% of individuals with DS have mosaic-type DS, with a cell population containing both typical and trisomy 21 karyotype. The phenotype is often believed to be milder than trisomy 21, but cognitive and behavioural profiles vary.

Subsequent investigations immediately after birth

It is important to note specific medical conditions that increase suspicion of DS.[17][28] Some infants with DS may not have the constellation of physical characteristics but present with associated medical conditions.

  • Evaluation by a paediatric cardiologist, including an echocardiogram, is recommended in all newborns with DS (even in the absence of a murmur). About 50% have CHD.[29]

  • An abdominal x-ray may be needed in some infants with DS, as they may be born with a gastrointestinal obstruction such as duodenal or anal stenosis or atresia (5% to 12%).​[17][30]​ This should be obtained in any newborn with DS presenting with vomiting, abdominal distention, or delay in stool passage.

  • Signs of feeding difficulty should be assessed, especially in the presence of marked hypotonia, poor weight gain, slow feedings or choking with feeds, recurrent or persistent respiratory symptoms, and oxygen desaturation with feeding. Video feeding study and/or nonradiologic videofluoroscopic swallow tests may be indicated if signs are present.

  • In the UK, screening for congenital hypothyroidism is conducted as part of the newborn blood spot screening programme, and hearing tests are conducted within the first 4-5 weeks of life.[31][32] Hearing screen and thyroid tests are required in all newborns in the US. Requirements may vary internationally; please consult local guidance.

  • A careful ophthalmological examination should be done in the newborn period because some infants with DS can have glaucoma or congenital cataracts. Cataracts can be assessed via a red reflex test.

  • Full blood count with differential should be ordered within 3 days of birth to assess for haematologic abnormalities such as transient abnormal myelopoiesis and polycythaemia.

Ongoing monitoring for complications in childhood

The American Academy of Pediatrics has developed health supervision guidelines for managing the care of children and adolescents with DS in the US.[17] Children with DS should receive the same preventive health care as any child, with additional monitoring as indicated. For example, children with DS are at increased risk of hearing and visual dysfunction, thyroid problems, and haematologic abnormalities compared to children without DS. Physicians should also continue to monitor the child's developmental, educational, behavioural, and social functioning.

See Monitoring for full details.

Use of this content is subject to our disclaimer